Nuvo Receives IND Clearance From FDA to Begin Clinical Testing of Lidocaine Spray

Nuvo Research announced that the FDA has cleared the company’s investigational new drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation, allowing for initiation of Phase 1 studies.
The Sacramento Bee